Funding will support global expansion of ScalaOS, a hybrid AI-driven protein design platform enabling faster development and optimization of biologics, enzymes, antibodies and vaccines| Read More ynet – Business
Scala Biodesign secures $16M to expand AI-driven protein development with ScalaOS
0 Comments